Transdermal Pain Relief and Skin Treatment Compositions

Publication ID: 24-11857676_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Transdermal Pain Relief and Skin Treatment Compositions,” Published Technical Disclosure No. 24-11857676_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857676_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,676.

Summary of the Inventive Concept

This inventive concept leverages the core technology of oral pain relief compositions to develop novel transdermal compositions for treating skin irritations, nail fungus, and preventing skin infections, offering a new paradigm for topical pain relief and skin care.

Background and Problem Solved

The original patent disclosed compositions for oral pain relief, addressing the need for effective pain management in dental care. However, skin irritations, nail fungus, and skin infections are prevalent issues that require innovative solutions. The new inventive concept adapts the core technology to tackle these unmet needs, providing a transdermal approach that bypasses oral administration and targets specific skin conditions.

Detailed Description of the Inventive Concept

The inventive concept comprises dissolvable carriers containing a combination of active ingredients, including guaiacol, eugenol, glycerin, menthol oil, peppermint oil, oregano oil, and cardamom oil. These carriers are designed to adhere to surfaces exhibiting skin irritations, nail fungus, or skin conditions, and dissolve over time to release the active ingredients. The compositions can be formulated as systems, methods, or topical applications, offering versatility in treating various skin-related issues.

Novelty and Inventive Step

The new claims introduce the concept of transdermal delivery of the active ingredients, which is a significant departure from the original oral pain relief compositions. The inventive step lies in the adaptation of the core technology to address unmet needs in skin care, leveraging the unique properties of the active ingredients to provide effective pain relief and treatment of skin conditions.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the ratio of active ingredients, incorporating additional ingredients for enhanced efficacy, or developing customized carriers for specific skin conditions. Variations could also involve using different types of carriers, such as patches, gels, or creams, to expand the range of applications.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the skin care and dermatology markets, addressing a wide range of skin-related issues. Target industries include pharmaceuticals, cosmetics, and personal care, with potential applications in wound care, dermatological treatments, and over-the-counter pain relief products.

CPC Classifications

SectionClassGroup
A A61 A61K9/006
A A61 A61K31/045
A A61 A61K31/047
A A61 A61K31/085
A A61 A61K36/53
A A61 A61K36/534
A A61 A61K36/9064
A A61 A61K47/10
A A61 A61K47/26
A A61 A61P23/02

Field of Art

Pharmaceutical compositions and topical drug delivery systems, specifically focusing on pain relief and skin treatment formulations involving essential oils and natural compounds

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced training in pharmaceutical sciences, organic chemistry, and drug delivery technologies, possessing expertise in formulating therapeutic compositions with natural ingredients and understanding transdermal/topical delivery mechanisms

Obviousness Rationale

A PHOSITA would recognize that the transdermal application of the source patent's oral pain relief composition represents a predictable extension of the original technology, leveraging the known therapeutic properties of the active ingredients in a different delivery format. The core chemical composition remains substantially unchanged, with only the carrier and application method being modified. The essential oils and compounds demonstrate well-understood antiseptic, analgesic, and anti-inflammatory properties that would naturally suggest broader application beyond oral contexts.

Obvious Combinations & Variations

Source Patent Element
Oral pain relief composition containing guaiacol, eugenol, glycerin, menthol, peppermint oil, oregano oil, and cardamom oil
PTD Variation
Transdermal and topical application of identical active ingredient composition for skin irritation and infection treatment
Obviousness Reasoning
Known therapeutic ingredients with established antiseptic and analgesic properties can be predictably applied to alternative treatment contexts using standard pharmaceutical formulation techniques
Source Patent Element
Dissolvable carrier composition with specific ingredient ratios
PTD Variation
Adapting carrier to adhere to skin surfaces and dissolve over time for localized treatment
Obviousness Reasoning
Carrier modification represents a routine design choice for a PHOSITA seeking to expand delivery mechanisms for known therapeutic compounds
Source Patent Element
Active ingredients with established pain relief properties
PTD Variation
Extending treatment applications to nail fungus and skin infection prevention
Obviousness Reasoning
Recognizing broader therapeutic potential of known compounds through systematic exploration of their inherent chemical properties is an expected scientific approach
Source Patent Element
Composition containing natural essential oils
PTD Variation
Creating alternative delivery systems like patches, gels, and creams
Obviousness Reasoning
Pharmaceutical formulation involves routine experimentation with delivery mechanisms to optimize absorption and efficacy of known active ingredients
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would have been obvious to a Person Having Ordinary Skill In The Art at the time of invention, as the transdermal and topical applications of the active ingredient composition from US Patent 11857676 represent predictable extensions of the original oral pain relief technology, utilizing standard pharmaceutical formulation techniques and leveraging the well-established therapeutic properties of the disclosed natural compounds.

Original Patent Information

Patent NumberUS 11,857,676
TitleCompositions for oral pain relief
Assignee(s)ORCA PRODUCTS, LLC